Skip to main navigation
About Us
Leadership
Board of Directors
Science
About CNM-Au8®
Pipeline
Patients
EAP
Investors
Overview
News & Events
Press Releases
News
Events
Presentations
Investor Presentation
Scientific Posters & Presentations
Webinars
Publications
Corporate Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Financial Information
SEC Filings
Annual Reports
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Contact
About Us
Leadership
Board of Directors
Science
About CNM-Au8®
Pipeline
Patients
EAP
Investors
Overview
News & Events
Press Releases
News
Events
Presentations
Investor Presentation
Scientific Posters & Presentations
Webinars
Publications
Corporate Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Financial Information
SEC Filings
Annual Reports
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Contact
Event Details
Clene’s Healey ALS Platform Trial Data Update
Mar 9, 2023 at 7:30 AM EST
Webcast
Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2024 Clene Nanomedicine, Inc. - All rights reserved
